// App-Quantinova.ai

4855 : Discovery of NVP-HDM201 - First disclosure of a Next-Generation Mdm2 inhibitor with superior characteristics

Researchers

Presenter

  • Philipp Holzer

Principal Investigators

  • Patrick Chene

  • Stephane Ferretti

  • Pascal Furet

  • Tobias Gabriel

  • Bjoern Gruenenfelder

  • Vito Guagnano

  • Francesco Hofmann

  • Joerg Kallen

  • Robert Mah

  • Keiichi Masuya

  • Rita Ramos

  • Stephan Ruetz

  • Caroline Rynn

  • Therese Stachyra-Valat

  • Stefan Stutz

  • Andrea Vaupel

  • Sebastien Jeay

Medical Centers

  • Novartis Institutes for BioMedical Research, Basel, Switzerland

Locations

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • HDM 201

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved